Prostatic Neoplasms: all 6,484 studies
Page 49 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using CyberknifeStatus unknownNCT02145494Phase 2
- Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing SurgeryCompletedNCT02144649Not applicable
- An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate CancerTerminatedNCT02140138Phase 2
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate CancerTerminatedNCT02139774
- Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyCompletedNCT02139371Early Phase 1
- Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate BiopsyStatus unknownNCT02138760Not applicable
- Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate CancerCompletedNCT02137746Phase 2
- Motorised Probe Holder Assisting Prostate BiopsiesCompletedNCT02132975Not applicable
- Men's Prostate Awareness Church TrainingCompletedNCT02131779Not applicable
- PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-ProstatectomyCompletedNCT02131649Not applicable
- MRI Before Biopsy in Diagnosing Patients With Prostate CancerTerminatedNCT02131207
- Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or EnzalutamideWithdrawnNCT02130947Not applicable
- Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast CancerCompletedNCT02130700Phase 2
- An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian FederationCompletedNCT02128334
- Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate CancerTerminatedNCT02125617
- Sequencing Abiraterone and Enzalutamide in mCRPCCompletedNCT02125357Phase 2
- BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate CancerCompletedNCT02125175Not applicable
- Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate CancerCompletedNCT02125084Phase 1
- A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompletedNCT02124668Phase 2
- Simultaneous CBCT Acquisition During Arc RadiotherapyStatus unknownNCT02123888Not applicable
- Cultured Circulating Tumor Cells in Prostate and Other CancersStatus unknownNCT02123862
- A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT02123758Phase 1
- Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP ChemotherapyCompletedNCT02121639Phase 1/2
- 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate CancerTerminatedNCT02121600Not applicable
- Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing SurgeryCompletedNCT02119858Phase 1
- T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT02113657Early Phase 1
- Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer PatientsCompletedNCT02111954
- Prostate Cancer Parameters for Patients Receiving Proton TreatmentWithdrawnNCT02110849
- Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following ProstatectomyCompletedNCT02110667
- Living Well on Androgen Deprivation TherapyWithdrawnNCT02108613Not applicable
- Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical ProstatectomyCompletedNCT02108431Not applicable
- Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate CancerCompletedNCT02107430Phase 2
- Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate CancerCompletedNCT02107404Phase 2
- Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate CancerCompletedNCT02107391Phase 2
- Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate CancerCompletedNCT02107287Not applicable
- ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone AcetateCompletedNCT02106507Phase 1
- Use of PET/MRI Tracer to Further Understanding of Prostate Cancer DevelopmentCompletedNCT02106416Not applicable
- Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerCompletedNCT02105675Phase 2
- Single Fraction Early Prostate Irradiation (SiFEPI)CompletedNCT02104362Not applicable
- Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their PartnersCompletedNCT02103088Not applicable
- MRI Substudy; Metabolic Changes Due to Iatrogenic HypogonadismCompletedNCT02102646Phase 4
- Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)TerminatedNCT02095717Phase 2
- Prostate Hypoxia - TICActive, not recruitingNCT02095249Not applicable
- Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate CancerSuspendedNCT02091661Phase 3
- Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese MenCompletedNCT02088164
- Problem Solving Therapy for Prostate Cancer Spousal CaregiversCompletedNCT02085096Not applicable
- Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After SurgeryCompletedNCT02080689Not applicable
- Robot-Assisted MRI-Guided Prostate BiopsyCompletedNCT02080052Not applicable
- Robotic Athermal Nerve-Sparing Radical ProstatectomyWithdrawnNCT02079155Not applicable
- Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)CompletedNCT02077634Phase 2
- Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate CancerActive, not recruitingNCT02077335Phase 2
- Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node StatusCompletedNCT02076503Not applicable
- Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate CancerCompletedNCT02074137Phase 4
- CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate CancerStatus unknownNCT02070952Not applicable
- Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical RecurrenceCompletedNCT02070575
- A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate CancerCompletedNCT02066961
- A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADTWithdrawnNCT02065323Phase 2
- High-dose Vitamin D Supplementation for ADT-induced Side EffectsCompletedNCT02064946Not applicable
- Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate CancerCompletedNCT02064608Phase 1
- Early Assessment of Treatment Response Using Functional Diffusion MappingCompletedNCT02064283Not applicable
- Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateCompletedNCT02064036Phase 1
- Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent PatientsStatus unknownNCT02058680Phase 1
- Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate CancerTerminatedNCT02055846Not applicable
- Sulforadex in Healthy Human Males MADCompletedNCT02055716Phase 1
- Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)WithdrawnNCT02054793Phase 1/2
- Prostate Cancer Screening Among Men With High Risk Genetic PredispositionStatus unknownNCT02053805Not applicable
- Testing Decision Aids About Early Stage Prostate CancerCompletedNCT02053389Not applicable
- Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal AgentsWithdrawnNCT02053311Phase 3
- Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 WeeksTerminatedNCT02051218Phase 3
- Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation TherapyCompletedNCT02050906Not applicable
- Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.CompletedNCT02050542Not applicable
- Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerStatus unknownNCT02049190Phase 1/2
- Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate CancerCompletedNCT02048150Phase 1
- An Exercise Trial and Economic Analysis in Men With Prostate CancerCompletedNCT02046837Phase 2
- Prostate Testing for Cancer and TreatmentActive, not recruitingNCT02044172Not applicable
- Strategies to Improve Bone Health in Men on ADTCompletedNCT02043236Not applicable
- Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVRCompletedNCT02043184Not applicable
- A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerTerminatedNCT02042885Phase 1/2
- To Evaluate the Effect of MCS® in Prostate Cancer PreventionActive, not recruitingNCT02042807Phase 2
- PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate CancerTerminatedNCT02042053Not applicable
- The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective StudyStatus unknownNCT02041559
- CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate CancerStatus unknownNCT02037464Phase 2
- Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate CancerCompletedNCT02036918Phase 1
- Prehabilitation for Prostate Cancer SurgeryCompletedNCT02036684Phase 1/2
- Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.CompletedNCT02036060Phase 2
- Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With DocetaxelWithdrawnNCT02035124Phase 2
- Prostatectomy Adaptive Radiation Therapy (ART)CompletedNCT02034955Not applicable
- Multi-site Decision Impact Study for DecipherCompletedNCT02034825
- Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation OncologistsCompletedNCT02034812
- Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in MenCompletedNCT02033447Early Phase 1
- Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy.CompletedNCT02033343Not applicable
- Treatment Decision Analysis Model for Prostate Cancer: A Randomized TrialTerminatedNCT02024685Not applicable
- Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing SurgeryCompletedNCT02024178Not applicable
- Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate CancerActive, not recruitingNCT02023463Phase 1
- Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition BiologyWithdrawnNCT02022904Not applicable
- Prostate Cancer Genomic HeterogeneityCompletedNCT02022371Phase 1/2
- Decision Impact Study to Measure the Influence of DECIPHER on Treatment RecommendationsCompletedNCT02020876
- Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate CancerCompletedNCT02020291Phase 1
- Focal Therapy Using HIFU for Localised Prostate CancerStatus unknownNCT02016040Phase 2/3
- An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate CancerCompletedNCT02015871Phase 3